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Five monoclonal antibodies against N-terminal domains of a- or &tubulin were tested for their ability to interfere with the in vitro formation 
of ~~ro~bules. Although all the antibodies exhibited similar association constants for ~obili~ tubulin, they differed in their inhibitor effect 
on microtubule assembly. For the most potent antibody, TU- 13, the anti~dy/tubulin molar ratio of about 1:320 was sufficient for a 5% inhibition. 
The data indicate that the surface regions of N-terminal domains of tubulin are involved in the formation of microtubules. 
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1. INTRODUCTION 
Tubulin, the major component of microtubules, con- 
sists of two subunits (or and 8) with a molecular weight 
of 50 000 each [l], that can be subdivided into N- 
terminal and C-terminal structural domains flz]. 
Although a model arrangement of these domains within 
a tubulin heterodimer has been proposed [3], there is lit- 
tle information on the participation of tubulin domain 
surfaces in the microtubule assembly. One possible ap- 
proach to the structural and functional mapping of the 
tubulin molecule is the application of domain-specific 
antibodies [4]. Here were report the differential in- 
hibitory effect of mAbs against N-terminal domains of 
tub&n subunits on in vitro assembly of microtubules. 
2. MATERIAL AND METHODS 
2.1. Protein preparation 
MTP was isolated from porcine brain according to [5] and the 
microtubule sediment resulting from the second reassembly cycle was 
dissolved in 20 mM MES, pH 6.4, 80 mM NaCl, 0.5 mM MgC12, 1 
mM EGTA (buffer A). The preparation contained more than 85% of 
tubulin as assessed by SDS-PAGE [6] and densitometric scanning of 
the gel. Tubulin was separated from the associated proteins as 
described in [7]. Protein concentration was determined according to 
[8] using bovine serum albumin as a standard. 
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Microtubules were prepared by polymerizing purified tubulin (0.5 
mg.ml- ‘) for 30 min at 37°C in buffer A supplemented with 10 PM 
taxol, 1 mM GTP. After adding of mAbs (1:lO mAb/tubulin molar 
ratio) the microtubules were incubated 30 min at 37’C and pelleted at 
200 000 x g for 30 min at 25°C &rough a cushion of 4 M glycerol in 
buffer A. The protein content of the pellet was determined on 12.5Yo 
SDS-PAGE. 
2.5. Solid phase radiometric assay 
Abbreviations: (m)Ab(s), (monoclonal)antibody(ies); MES, 2-(N- Measurements of the reactivity of various mAbs with tubulin were 
morpholino)ethanesulphonic a id: MTP, microtubule protein; SDS- Performed as in [15] using Terasaki microplates coated with tubulin 
PAGE, polyacrylamide gel electrophoresis with sodium dode- and ‘251-labelled SWAM (16 cpm per well, sp. act. approximately 370 
cyls~phate; SWAM. swine antibody against mouse immunogIobulin kBq.Fg-‘). 
2.2. Antibodies 
Mouse mAbs TU-02, TU-03, TU-04, TU-07, TU-09 against he o- 
subunit of tubulin, and mAbs TU-06, TU-13 against the fl-tubulin 
have been previously described [9,10]. The mouse mAb TEC-01 
against the carbohydrate pitope of teratocarcinoma stem cells [I if 
was used as a negative control. All mAbs belonged to the IgM class. 
The mAbs were purified from a&tic fluid [9], dialyzed against 
phosphate-buffered saline, pH 7.2 and centrifuged at 100 000 x g for 
20 min at 4*C. The mAb purity attained was higher than 80%. 
2.3. Turbidimetric measurements 
The microtubule assembly was monitored by turbidimetric 
me~urements (121 at 360 nm and 37OC in 0.5 cm cuvettes using the 
spectrophotometer SPECORD UV VIS with tem~rature~ontrolled 
cuvette holder (Carl Zeiss, Jena, GDR). The assembly was initiated by 
an addition of cold (4°C) MTP and GTP solutions to the prewarmed 
(37°C) mAbs at various concentrations (method I) [13]. The resulting 
assembly mixture contained 1.5-1.8 mg*ml- ’ MTP in 10 mM MES, 
105 mM NaCI, 5 mM NazHP04, 0.25 mM MgCL, 0.5 mM EGTA, 
0.36 mM GTP. To ~stinguish between the turbidity caused by 
microtubule formation and that caused by non-microtubular ag- 
gregates, the turbidity drop after 5 min cold (4’C) incubation was 
recorded (method II). Electron microscopy [14] verified that the 
microtubules completely disassembled after cold incubation. To test 
the microtubule-destroying action of mAbs, these were added to 
preformed microtubules and the mixtures were incubated for 20 min 
at 37°C. 
2.4. Sedimentation assay 
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Fig.1. Binding of antibodies to immobilized tubulin as revealed by 
solid phase binding assay [15] using ‘*sI-labelled SWAM 
(105cpm/well), G-0, TU-02; P-V, TEC-01. 
3. RESULTS 
In the solid phase radiometric assay, all anti-tubulin 
mAbs gave titers similar to those shown for TU-02 in 
fig. 1. The results indicate no substantial differences in 
the association constants between the mAbs and the 
tubulin. The TWO2 inhibited polymerization of MTP in 
vitro as can be inferred from the results of turbidimetric 
measurements; i.e., the lag phase of assembly was 
slightly prolonged and the extent of assembly (A& was 
reduced. After cold incubation turbidity (ticold) did 
not drop completely to the initial basal level (fig.2), in- 
dicating the formation of a few nonmicrotubular ag- 
gregates. The assembly inhibition was concentration- 
dependent. In a similar way, microtubule assembly was 
also suppressed by the mAbs TU-03, TU-06 and TU-13 
(table 1). An incubation (up to 30 min at 4°C) of mAbs 
with MTP prior to the assembly did not change the in- 
hibitory action. The microtubule formation was not 
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Fig.2. Time course of microtubule polymerization in the absence 
(- ) and presence (- - -) of TU-02 (47 nM). O-20 min, incubation 
at 37°C; 20-27 min, incubation at 0°C. Assembly extent at 37°C in 
the absence (control, AAc) or presence (AA) of TU-02. Drop in the 
assembly extent at 0°C in the absence (control, ticold,C) or presence 
@&Id) of mAb. 
Table 1 
Effect of antibodies on microtubule assembly as assessed by 
turbidimetric measurements 
Antibody Concentration of mAbs (nM) 
causing 50% inhibition 
Method I Method II 
TU-02 170 145 
TU-03 50 50 
TU-04 >330 >330 
TU-06 150 n.m. 
TU-09 >360 >360 
TU-13 35 40 
TEC-01 >350 >350 
The extent of MTP assembly (concentration of tubulin approximately 
12-14 PM) was determined either by (&J/A,&). 100% (Method I) or 
by @&ld/&&,ld,c) 100% (Method II). For explanation of the sym- 
bols see fig. 2; n.m., not measurable because of strong increase in tur- 
bidity at 4°C. 
significantly inhibited by the mAbs TU-04, TU-09 and 
TEC-01, while the mAb TU-07 precipitated MTP. The 
mAbs which exhibited an inhibitory effect also partially 
disrupted the preformed steady-state microtubules. 
However, the disrupting activity was weaker than the 
inhibitory effect. The sedimentation assay using taxol- 
stabilized microtubules and the mAb TU-13, which had 
been found to possess the strongest inhibitory power, 
showed an almost undetectable binding of the mAb to 
the microtubules contrary to the mAb TU-07 (fig.3). 
4. DISCUSSION 
The influence of N-terminal tubulin domains on the 
process of microtubule assembly in vitro was studied by 
means of the mAbs TU-02, TU-03 and TU-09 binding 
to the N-terminal domain of a-subunit, as well as the 
TU-06 binding to the N-terminal domain of P-subunit 
[9]. The epitope recognized by the mAb TU-13 is also 
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Fig.3. SDS-PAGE analysis of the binding of anti-tubulin antibodies 
to taxol-stabilized microtubules. Antibodies TU-13 (lanes 1,2) and 
TU-07 (lanes 3,4) were incubated with taxol-microtubules and 
pelleted through the 4 M glycerol cushion. Lanes 1,3, mixtures before 
centrifugation; lanes 2,4, corresponding pellets; HC, IgM heavy 
chain; LC, IgM light chain; T, tubulin. 
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located in the N-terminal domain of &tubulin [un- 
published]. The mAbs TU-04 and TU-07 against C- 
terminal domain of cr-subunit and against conforma- 
tional epitope of ar-tubulin, respectively, were used as a 
control [9]. Our data show that some mAbs against he 
N-terminal domains of tubulin subunits can strongly in- 
hibit the microtubule assembly. The results of the solid 
phase radiometric assay indicated that the differential 
inhibition effect of mAbs was not due to differences in 
the association constants between the mAbs and 
tubulin. 
Whereas some polyclonal anti-tubulin Abs or their 
F ab fragments are known to be able to inhibit 
microtubule assembly in vitro at the 1:l Ab/tubulin 
molar ration [2], mAbs tested so far had reportedly no 
effect on microtubule assembly in vitro [16]. Some of 
the mAbs tested here do inhibit the microtubule forma- 
tion even at substoichiometric oncentrations e.g. 50% 
inhibition by TU-13 at a mAb-tubulin molar ratio of 
approximately 1:320. In the experiments measuring the 
association of TU-13 with taxol-stabilized microtubules 
we were unable to detect the binding of TU-13 even at 
higher mAb concentrations. To explain the inhibition 
mechanism, it could be assumed that the active mAbs 
block the microtubule formation by binding to the 
microtubule ends. Since steady-state microtubules 
reveal remarkable length fluctuations at both ends [ 171, 
such a capping phenomenon could also explain the 
disruption of preformed microtubules. Microinjection 
experiments could reveal whether or not the mAbs in- 
fluence the stability of microtubules also in vivo. Rever- 
sible disruption of cytoplasmic microtubules in living 
cells by high affinity polyclonal antibody to P-tubulin 
has already been described [ 181. 
In summary, we described for the first time an in- 
hibitory effect of domain-specific mAbs on micro- 
tubule assembly in vitro. Our data suggest hat surface 
regions of N-terminal domains of both tubulin subunits 
are involved in the formation of microtubule structures. 
Some of the target epitopes recognized by the inhibitory 
antibodies could be essential for tubulin polymeriza- 
tion. 
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